Feng et al. (2019) demonstrated that NIBAN1 interacts with the TIMP-1/MMP2/MMP9 pathway, interfering with the processes of cell migration, invasion and proliferation, in clear cell renal carcinoma (ccRCC), the most aggressive subtype of renal cancer, contributing to tumor progression. This evidence concerns the gene NIBAN1 and neoplasm.